Co-Authors
This is a "connection" page, showing publications co-authored by Fernando Bozza and Mayara Mattos.
Connection Strength
0.291
-
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
Score: 0.059
-
Correction: SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 May 19; 7(1):116.
Score: 0.059
-
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discov. 2021 Mar 01; 7(1):43.
Score: 0.058
-
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020 12; 16(12):e1009127.
Score: 0.057
-
Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrob Agents Chemother. 2020 09 21; 64(10).
Score: 0.056